Can a reformulated gel plus light therapy better tackle precancerous skin spots?
NCT ID NCT07729579
First seen Jul 27, 2026 · Last updated Aug 14, 2026 · Updated 3 times
Summary
This trial is testing a reformulated version of a topical drug called Levulan Kerastick, which is applied to actinic keratosis (AK) lesions on the face or forearms. After the drug sits on the skin for a few hours, it is activated by blue light in a process called photodynamic therapy (PDT). The study aims to measure how much of the drug enters the bloodstream and to check for any side effects in people with multiple AK spots.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- a reformulated topical solution of aminolevulinic acid hydrochloride (ALA HCl) 20%, applied as Levulan Kerastick followed by blue light photodynamic therapy
- What this could lead to
- If successful, this could lead to a more effective and convenient treatment for actinic keratosis, a common precancerous skin condition.
- What could go wrong
- This is an early phase 1 study with only 48 participants, so it is primarily checking safety and how the drug moves through the body, not yet whether it works better than existing treatments. Side effects from the drug or light therapy are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACTINIC KERATOSIS (AK) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
J&S Studies
RECRUITINGCollege Station, Texas, 77845, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a five-day ointment improve sun-damaged skin? new study investigates
- New cream could zap precancerous skin spots
- Can a special sunscreen stop skin spots from turning dangerous?
- Half the time, same effect? new study tests shorter light therapy for scalp lesions
- New ointment for Sun-Damaged skin spots enters early human testing
- Simple cream may shield transplant patients from skin cancer